Abstract:In this state-of-the-art review we detail the journey of xenotransplantation from its infancy, detailing one of the first published cases and the subsequent journey the field took in its inception and development. With a focus on the science, technological advances, precautions required along with the potential limitations in application, the ethics, guidance’s, and legislative advances that are required to reach the safe and efficacious clinical application of xenotransplantation. Along with a view over the past several decades with the overall significant advancements in pre-clinical study outcomes particularly in islet, kidney, and heart xenotransplantation, to ultimately reach the pinnacle of successful clinical heart and kidney xenotransplants. It outlines the importance for the appropriate guidance’s required to have been developed by experts, scientists, clinicians, and other players who helped develop the field over the past decades. It also touches upon patient advocacy along with perspectives and expectations of patients, along with public opinion and media influence on the understanding and perception of xenotransplantation. It discusses the legislative environment in different jurisdictions which are reviewed in line with current clinical practices. All of which are ultimately based upon the guidance’s developed from a strong long-term collaboration between the International Xenotransplantation Association, the World Health Organisation and The Transplantation Society; each having constantly undertaken consultation and outreach to help develop best practice for clinical xenotransplantation application. These clearly helped forge the legislative frameworks required along with harmonization and standardization of regulations which are detailed here. Also, in relation to the significant advances in the context of initial xeno-kidney trials and the even greater potential for clinical xeno-islet trials to commence we discuss the significant advantages of xenotransplantation and the ultimate benefit to our patients.

National policies for xenotransplantation in the USA *

Xenotransplantation in Australia: Development of the regulatory process

Ethical and legislative advances in xenotransplantation for clinical translation: focusing on cardiac, kidney and islet cell xenotransplantation

Unaddressed regulatory issues in xenotransplantation: a hypothetical example

Update on the ethical, legal and technical challenges of translating xenotransplantation

Public attitudes to xenotransplantation: A national survey in the United States

Research opportunities and ethical considerations for heart and lung xenotransplantation research: A report from the National Heart, Lung, and Blood Institute workshop

Xenotransplantation: A New Era

Comparison of the antiviral efficacy of ribozymes and antisense RNA directed against bovine leukemia virus rex/tax.

The importance of public engagement in clinical xenotransplantation

Xenotransplantation: Where are we in 2008?

[Epidemiological characteristics of elderly dialysed patients aged 75 and more. Study conducted in the Provence-Alpes-Côte d'Azur region of France].

Phytochemical and pharmacological studies on Viscum album L. VII. Preliminary end-group studies of the main oxidation product of viscotoxin A.

Xenotransplantation Literature Update December 2023–June 2024

Xenotransplantation: A historical-ethical account of viewpoints

Solid organ xenotransplantation at the interface between research and clinical development: Regulatory aspects

Update on cellular encapsulation

Xenotransplantation--how far have we come?

Prospects for xenotransplantation

Xenotransplantation: An Overview of the Field

Expert consensus on clinical trials of human xenotransplantation in China